Telix Pharmaceuticals
TLX10.0600.40% ( -0.040 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Telix Pharmaceuticals(TLX) predict that the Revenue is 227.79 M (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.23B--
0.21B--
+0.01B--%
EBIT
TBA--
0.01B--
----
EPS
TBA--
-0.0096--
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf